[
  {
    "ts": null,
    "headline": "Pfizer: Finally Some Fortune, Plus Twenty High-Quality Dividend Growth Valuations",
    "summary": "Discover high-quality dividend-growth stocks near 52-week lows. Explore Pfizer's strong dividend and valuations, plus other top picks like Merck and Qualcomm.",
    "url": "https://finnhub.io/api/news?id=ec425284e980cf083d7d06feec4294590bc48a5d33b2fdd798c828b58de26570",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756315645,
      "headline": "Pfizer: Finally Some Fortune, Plus Twenty High-Quality Dividend Growth Valuations",
      "id": 136542130,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2203006359/image_2203006359.jpg?io=getty-c-w1536",
      "related": "ELV",
      "source": "SeekingAlpha",
      "summary": "Discover high-quality dividend-growth stocks near 52-week lows. Explore Pfizer's strong dividend and valuations, plus other top picks like Merck and Qualcomm.",
      "url": "https://finnhub.io/api/news?id=ec425284e980cf083d7d06feec4294590bc48a5d33b2fdd798c828b58de26570"
    }
  },
  {
    "ts": null,
    "headline": "Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup",
    "summary": "UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.",
    "url": "https://finnhub.io/api/news?id=925bcda085a693d8666c795f74fd5d7134671149c4d8dca01a1d50e8a3b2af40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756305060,
      "headline": "Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup",
      "id": 136539609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.",
      "url": "https://finnhub.io/api/news?id=925bcda085a693d8666c795f74fd5d7134671149c4d8dca01a1d50e8a3b2af40"
    }
  },
  {
    "ts": null,
    "headline": "CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?",
    "summary": "CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.",
    "url": "https://finnhub.io/api/news?id=9fc5d35865b9115b861c2a6f95a24a6a502962296ccbf17774f2f0fc251b1db4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756300860,
      "headline": "CVS vs. ELV: Which Healthcare Titan Is the Stronger Investment Today?",
      "id": 136539756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "CVS Health advances with Aetna margin recovery, digital investments and cost savings, making it the stronger healthcare bet over Elevance.",
      "url": "https://finnhub.io/api/news?id=9fc5d35865b9115b861c2a6f95a24a6a502962296ccbf17774f2f0fc251b1db4"
    }
  }
]